When you go to “COOKIES INCL. ALLOW US SERVICES” click, you agree to the storage of cookies on your device to improve website navigation, analyze site usage, and support our marketing efforts. For more information, see our Privacy statement.

IMPACT®

IMPACT® is a platform for autologous cell therapies.

Fully automated system for equal & high-quality results

Faster & safer therapy through advanced and scientifically proven programs that provide consistent results for every patient.

Precise adaptability of leukocytes and thrombocytes

Targeted adjustment of blood cell concentrations for optimized, patient-specific therapies.

Improving clinical outcomes

Better patient outcomes through increased cell concentrations in therapy.

Areas of application

Areas of application of IMPACT®

Orthopedics, traumatology and sports medicine

Accelerates healing for sports injuries and chronic musculoskeletal complaints.

Plastic surgery

Improves healing processes and results after aesthetic surgery

Dermatology

Use for hair loss and scar treatment for skin regeneration.

Dentistry

Supports rapid healing and bone growth after dental surgery

General surgery

Promotes rapid wound healing, reduces complications after surgery

Rheumatology

Treats inflammatory joint diseases in a targeted and autologous manner.

Versatile therapy solutions with one system

The IMPACT® system revolutionizes the production of autologous cell therapies, also known as orthobiologics, on a single platform. These products, rich in growth factors, anti-inflammatory cytokines and stem cells, use the body's own regeneration mechanisms to naturally heal injured tissue.

Eine Hand mit blauen Handschuhen bedient den Touchscreen einer medizinischen Zentrifuge, um den Verarbeitungsmodus auszuwählen.

Programmable therapy cycles for repeatable quality

The IMPACT® system allows you to use preset therapy cycles or save your own to achieve consistent, repeatable medical results.

Individual dosing of active ingredients for improved healing results

Determine the composition of your therapies yourself and save your settings for repeated applications. Precisely adjust cytokines and growth factors to meet specific therapeutic needs.

Easy 6 step process

With IMPACT®, the desired blood fractions are centrifuged and separated fully automatically in a closed system. The syringe containing the patient's blood is inserted and after the program has ended, the desired autologous blood product is removed “ready-to-use”.

Blutabnahme Symbol
Step 1

Take blood

Remove 12 ml of whole blood.

2 Spritzen die verbunden werden
Step 2

Connect

Connect the whole-blood-filled syringe to an empty IMPACT® syringe using the supplied hose.

Spritzen aus der Vogelperspektive, wie sie in der Zentrifuge platziert werden.
Step 3

Placing

Insert the connected syringes into the rotor. If necessary, add a second tandem.

Zentrifugation
Step 4

centrifuging

Perform the first centrifugation to separate the desired blood fraction. If necessary, a second centrifugation follows, for example to produce a platelet concentrate.

Entnahme der Spritzen. Die Trennung der Blutbestandteile wird durch die Farbe Gelb in der einen Spritze und die Farbe Rot in der anderen Spritze gekennzeichnet.
step 5

Remove

Remove the syringes and turn off the syringe with the finished autologous blood product.

Die Spritze mit dem Konzentrat bei der Injektion im Knie.
Step 6

Inject

Inject the product into the affected area.

IMPACT® system products

ACS

Verpackung von IMPACT ACS
Inhibition of inflammation
Long-term pain relief
Lasting impact
More about IMPACT® ACS

ACS

Verpackung von IMPACT PRP
High concentration of growth factors
Wide range of applications: orthopedics, dermatology,...
Long-term tissue regeneration
More about IMPACT® PRP

ACS

Verpackung von IMPACT APC
Quick healing of acute injuries
High concentration of platelets
Controlled leukocyte enrichment
Learn more about IMPACT® APC

Product video

IMPACT® studies

The latest study results on IMPACT®
IMPACT Logo
Platelet-rich plasma is similar to platelet-rich plasma plus hyaluronic acid for the treatment of knee osteoarthritis at 2 years: a randomized controlled trial